Heparin Market (2023 to 2029) – Growth, Dynamics, Market Impacts and Forecasts

Heparin Market has valued at US$ 7.23 Bn in 2022. The Heparin Market size is estimated to grow at a CAGR of 1.6% over the forecast period.

Heparin Market Overview:

The Heparin Market analyzes and forecasts the market size in terms of value for the market (Billion). Further, the Heparin Market is segmented by Product Type, Route of Administration, End User, and Region. Based on Product Type, the market is segmented into Unfractionated Heparin (UFH), and Low Molecular Weight Heparin (LMWH). Based on the Route of Administration, the market is divided into Intravenous Infusion and Subcutaneous Injection. Based on End Users, the market is divided into Hospitals & ASCs, Clinics, and Others. North America is the dominant player in the market. The report thoroughly analyzes market drivers, limitations, and opportunities. The presentation of facts and figures gives key data for the historical period. The report explores the different segments and data that have been provided by market participants and regions. Unfractionated heparin (UFH), also known as heparin, is a naturally occurring glycosaminoglycan. It is utilized in medicines as an anticoagulant. Treatment of unstable angina and heart attacks benefits greatly from it. It is either injected into a vein or under the skin. It is used for various health conditions such as acute coronary syndrome, deep vein thrombosis, pulmonary embolism, atrial fibrillation, cardiopulmonary bypass, and blood filtration during cardiac surgery. Its use extends to performing major orthopedic surgeries such as hip and knee replacement.Heparin MarketTo know about the Research Methodology :- Request Free Sample Report

Heparin Market Dynamics:

Increasing Incidence of Chronic Cardiovascular and Other Diseases to Drive Market Growth The occurrence of cardiovascular illnesses is rising in important age groups, such as the elderly population which is expected to drive demand for this product is one of the major driving factors in the market. During the forecast period, it is anticipated that nearly all types of illness, including atrial fibrillation, heart attacks, and strokes to remain common. In 2020, the Centers for Disease Control and Prevention (CDC), around 655,000 Americans would die from cardiovascular illnesses. There a are few factors that contribute to the significant potential and current patient populations represented by these trends and statistics, which result in high demand for these products. The market will also fuel because people are becoming more aware of the medications' effectiveness in treating different cardiac diseases. So, during the forecast period, the frequency and incidence of cardiovascular illnesses would and are expected to drive the market growth. Strong Use of These Products in Several Applications to Promote Market Growth The effectiveness of these medications as an anticoagulant is one of the major reasons expected to fuel the market growth around the world. It is anticipated that indisputable variables like technological advancements and the introduction of new goods will fuel the growth of the market. The increase in the consumption of these medications has sped up the creation of LMWH. The ULMWH is one of the more recent types that have emerged as a result of technical improvements. During the forecast period, these factors are anticipated to have a favorable effect on the market. Lack of Raw Materials and Increased Costs of Some Types will Limit Market Growth A few issues limiting the growth of the market around the world include worries about the scarcity of raw materials that are imported from China for the production of products based on porcine. African Swine Fever (ASF), a swine-death disease, has recently caused numerous outbreaks in China. To control the outbreaks, pigs have mass-murdered. For example, a Chinese agriculture ministry official claimed that in July 2020, more than 11 outbreaks and the presence of novel strains made China’s attempts to contain the African swine flu. The latest outbreaks were noted in China’s northern provinces. Thus, this element may contribute to the ongoing scarcity of raw materials. The LMWH’s higher costs are the second limiting factor. These costs could prevent it from being adopted more widely in developing markets, and are expected to hinder the growth of the market in the forecast year.

Heparin Market Segment Analysis

Based on type, the low molecular weight segment accounted for the biggest market share for heparin because of the product’s more predictable anticoagulant effect. A study published in NEJM Journal Watch found that the segment growth is aided by the low prevalence of heparin-induced thrombocytopenia. Because of the development of products with improved pharmacological properties, ultra-low molecular weight heparin is anticipated to increase in the market during the forecast period. The LMWH market category had the most market share. Because of the high rate of adoption of this product type in developed markets, the high cost for this product, and the higher safety products relative to other types all contribute to the segment’s dominance. Fragmin, Lovenox, and Innohep are crucial medications. The main players have also been concentrating on creating and introducing new LMWH products into the international market. For example, Valeo Pharma Inc declared in November 2019 that they submitted a new drug submission for an LMWH biosimilar which Health Canada has approved for assessment. The UFH segment is expected to have a lesser market share during the forecast period this is mainly because there is a shift toward using LMWH and the worries about the safety profiles of this product class. Based on the Route of Administration, the subcutaneous injection segment is expected to dominate the market because the low molecular weight heparin is frequently injected under the skin. In comparison to other product options, these products are typically more expensive. The sector for intravenous infusion is expected to increase at a slower rate during the forecast period. It contains several well-known UFH products that are available for intravenous administration. Based on End Users, during the forecast period, hospitals and ASCs are anticipated to hold the largest market share around the world. This is mostly because of the high reliance on healthcare experts for the prescription of these medications and their appropriate delivery, particularly through intravenous infusion. Because many of these medications are provided at clinics, including dialysis centers, it is anticipated that the clinic sector will hold the second largest market share during the forecast period. The other market is anticipated to experience high CAGR, mainly because of the increase in the usage of LMWH through subcutaneous injection in a home care setting. Also, the retail pharmacies sell the products, this is because the fact that patients can feel more at ease and more convenient in homecare settings.Heparin Market

Heparin Market Regional Insights:

The heparin market is anticipated to grow at the fastest rate in emerging countries in the Asia Pacific during the forecast period because of the region’s continuously increasing healthcare infrastructure, the presence of untapped resources, economic development, and increasing private and public initiatives. The aging of the population and the availability of more patients with cardiovascular disorders are the factors that contribute to the growth of the market. The region is anticipated to fuel the growth of the heparin market because of the leading manufacturer increased focus on growing their geographic presence in developing Asia Pacific nations. The North American heparin market was valued at $777.5 million in 2022 because of the existence of prominent market participants like Pfizer and Amphastar and others. It is anticipated that region’s industry to rise as chronic diseases become more prevalent in North American Nations. For example, inherited thrombophilia is a condition in which a genetic defect can be identified that increases the risk for thrombosis. The Centers for Diseases Control and Prevention (CDC) forecast that between 5 to 8 % of Americans have one of several genetic risk factors. Heparin demand will rise thrombosis risk rises, supporting the North American market need. The objective of the report is to present a comprehensive analysis of the global Heparin Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Heparin Market dynamic, and structure by analyzing the market segments and projecting the Heparin Market size. Clear representation of competitive analysis of key players by Design, price, financial position, product portfolio, growth strategies, and regional presence in the Heparin Market make the report investor’s guide.

Heparin Market Scope: Inquire before buying

Heparin Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 7.23 Bn.
Forecast Period 2023 to 2029 CAGR: 1.6% Market Size in 2029: US $ 8.08 Bn.
Segments Covered: by Product Type Unfractionated Heparin (UFH) Low Molecular Weight Heparin (LMWH)
by End-User Hospitals & ASCs Clinics Others
by Route of Administration Intravenous Infusion Subcutaneous Injection

Heparin Market by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Heparin Market Key Players are:

1. Baxter International Inc. (US) 2. B. Braun Holding GmbH & Co. KG (Germany) 3. Dr. Reddy’s Laboratories Ltd (India) 4. Fresenius SE & Co KGaA (Germany) 5. Hebei Changshan Biochemical Pharmaceutical Co. Ltd (China) 6. Leo Pharma A/S (Denmark) 7. Pfizer Inc. (NY, US) 8. Sanofi S.A. (Paris, France) 9. Teva Pharmaceuticals (Israel) 10.Viatris Inc. (US) 11.Amphastar (US) 12.Sanofi (France) 13.Rovi (Spain) 14.Shenzhen Hepalink (China) Frequently asked questions: 1. What is the market growth of the Heparin Market? Ans. The Heparin Market was valued at USD 7.23 Billion in 2022 and is expected to reach USD 8.08 Billion by 2029, at a CAGR of 1.6% during the forecast period. 2. Which are the major key players in the Heparin Market? Ans. The key players in this market include Baxter International Inc., B. Braun Holding GmbH & Co. KG, Dr. Reddy’s Laboratories Ltd, Fresenius SE & Co KGaA. 3. Which region is anticipated to account for the largest market share? Ans. North America is anticipated to dominate the Heparin Market, 4. what is the forecast period for the Heparin Market? Ans. The forecast period for the Heparin Market is from 2023 to 2029. 5. what is the segment in which the Heparin Market is divided? Ans. The Heparin Market is fragmented based on Product Type, End-User, and Route of Administration. It is also divided on basis of different regions.
1. Heparin Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Heparin Market: Dynamics 2.1. Heparin Market Trends by Region 2.1.1. North America Heparin Market Trends 2.1.2. Europe Heparin Market Trends 2.1.3. Asia Pacific Heparin Market Trends 2.1.4. Middle East and Africa Heparin Market Trends 2.1.5. South America Heparin Market Trends 2.2. Heparin Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Heparin Market Drivers 2.2.1.2. North America Heparin Market Restraints 2.2.1.3. North America Heparin Market Opportunities 2.2.1.4. North America Heparin Market Challenges 2.2.2. Europe 2.2.2.1. Europe Heparin Market Drivers 2.2.2.2. Europe Heparin Market Restraints 2.2.2.3. Europe Heparin Market Opportunities 2.2.2.4. Europe Heparin Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Heparin Market Drivers 2.2.3.2. Asia Pacific Heparin Market Restraints 2.2.3.3. Asia Pacific Heparin Market Opportunities 2.2.3.4. Asia Pacific Heparin Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Heparin Market Drivers 2.2.4.2. Middle East and Africa Heparin Market Restraints 2.2.4.3. Middle East and Africa Heparin Market Opportunities 2.2.4.4. Middle East and Africa Heparin Market Challenges 2.2.5. South America 2.2.5.1. South America Heparin Market Drivers 2.2.5.2. South America Heparin Market Restraints 2.2.5.3. South America Heparin Market Opportunities 2.2.5.4. South America Heparin Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Heparin Industry 2.8. Analysis of Government Schemes and Initiatives For Heparin Industry 2.9. Heparin Market price trend Analysis (2021-22) 2.10. Heparin Market Trade Analysis 2.10.1. Global Import Analysis 2.10.1.1. Top Importer of Heparin 2.10.2. Global Export Analysis 2.10.2.1. Top Exporter of Heparin 2.11. Heparin Production Analysis 2.12. The Global Pandemic Impact on Heparin Market 3. Heparin Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value and Volume) 2022-2029 3.1. Heparin Market Size and Forecast, by Product Type (2022-2029) 3.1.1. Unfractionated Heparin (UFH) 3.1.2. Low Molecular Weight Heparin (LMWH) 3.2. Heparin Market Size and Forecast, by End-User (2022-2029) 3.2.1. Hospitals & ASCs 3.2.2. Clinics 3.2.3. Others 3.3. Heparin Market Size and Forecast, by Route of Administration (2022-2029) 3.3.1. Intravenous Infusion 3.3.2. Subcutaneous Injection 3.4. Heparin Market Size and Forecast, by Region (2022-2029) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Heparin Market Size and Forecast by Segmentation (by Value and Volume) 2022-2029 4.1. North America Heparin Market Size and Forecast, by Product Type (2022-2029) 4.1.1. Unfractionated Heparin (UFH) 4.1.2. Low Molecular Weight Heparin (LMWH) 4.2. North America Heparin Market Size and Forecast, by End-User (2022-2029) 4.2.1. Hospitals & ASCs 4.2.2. Clinics 4.2.3. Others 4.3. North America Heparin Market Size and Forecast, by Route of Administration (2022-2029) 4.3.1. Intravenous Infusion 4.3.2. Subcutaneous Injection 4.4. North America Heparin Market Size and Forecast, by Country (2022-2029) 4.4.1. United States 4.4.1.1. United States Heparin Market Size and Forecast, by Product Type (2022-2029) 4.4.1.1.1. Unfractionated Heparin (UFH) 4.4.1.1.2. Low Molecular Weight Heparin (LMWH) 4.4.1.2. United States Heparin Market Size and Forecast, by End-User (2022-2029) 4.4.1.2.1. Hospitals & ASCs 4.4.1.2.2. Clinics 4.4.1.2.3. Others 4.4.1.3. United States Heparin Market Size and Forecast, by Route of Administration (2022-2029) 4.4.1.3.1. Intravenous Infusion 4.4.1.3.2. Subcutaneous Injection 4.4.2. Canada 4.4.2.1. Canada Heparin Market Size and Forecast, by Product Type (2022-2029) 4.4.2.1.1. Unfractionated Heparin (UFH) 4.4.2.1.2. Low Molecular Weight Heparin (LMWH) 4.4.2.2. Canada Heparin Market Size and Forecast, by End-User (2022-2029) 4.4.2.2.1. Hospitals & ASCs 4.4.2.2.2. Clinics 4.4.2.2.3. Others 4.4.2.3. Canada Heparin Market Size and Forecast, by Route of Administration (2022-2029) 4.4.2.3.1. Intravenous Infusion 4.4.2.3.2. Subcutaneous Injection 4.4.3. Mexico 4.4.3.1. Mexico Heparin Market Size and Forecast, by Product Type (2022-2029) 4.4.3.1.1. Unfractionated Heparin (UFH) 4.4.3.1.2. Low Molecular Weight Heparin (LMWH) 4.4.3.2. Mexico Heparin Market Size and Forecast, by End-User (2022-2029) 4.4.3.2.1. Hospitals & ASCs 4.4.3.2.2. Clinics 4.4.3.2.3. Others 4.4.3.3. Mexico Heparin Market Size and Forecast, by Route of Administration (2022-2029) 4.4.3.3.1. Intravenous Infusion 4.4.3.3.2. Subcutaneous Injection 5. Europe Heparin Market Size and Forecast by Segmentation (by Value and Volume) 2022-2029 5.1. Europe Heparin Market Size and Forecast, by Product Type (2022-2029) 5.2. Europe Heparin Market Size and Forecast, by End-User (2022-2029) 5.3. Europe Heparin Market Size and Forecast, by Route of Administration (2022-2029) 5.4. Europe Heparin Market Size and Forecast, by Country (2022-2029) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Heparin Market Size and Forecast, by Product Type (2022-2029) 5.4.1.2. United Kingdom Heparin Market Size and Forecast, by End-User (2022-2029) 5.4.1.3. United Kingdom Heparin Market Size and Forecast, by Route of Administration(2022-2029) 5.4.2. France 5.4.2.1. France Heparin Market Size and Forecast, by Product Type (2022-2029) 5.4.2.2. France Heparin Market Size and Forecast, by End-User (2022-2029) 5.4.2.3. France Heparin Market Size and Forecast, by Route of Administration(2022-2029) 5.4.3. Germany 5.4.3.1. Germany Heparin Market Size and Forecast, by Product Type (2022-2029) 5.4.3.2. Germany Heparin Market Size and Forecast, by End-User (2022-2029) 5.4.3.3. Germany Heparin Market Size and Forecast, by Route of Administration (2022-2029) 5.4.4. Italy 5.4.4.1. Italy Heparin Market Size and Forecast, by Product Type (2022-2029) 5.4.4.2. Italy Heparin Market Size and Forecast, by End-User (2022-2029) 5.4.4.3. Italy Heparin Market Size and Forecast, by Route of Administration(2022-2029) 5.4.5. Spain 5.4.5.1. Spain Heparin Market Size and Forecast, by Product Type (2022-2029) 5.4.5.2. Spain Heparin Market Size and Forecast, by End-User (2022-2029) 5.4.5.3. Spain Heparin Market Size and Forecast, by Route of Administration (2022-2029) 5.4.6. Sweden 5.4.6.1. Sweden Heparin Market Size and Forecast, by Product Type (2022-2029) 5.4.6.2. Sweden Heparin Market Size and Forecast, by End-User (2022-2029) 5.4.6.3. Sweden Heparin Market Size and Forecast, by Route of Administration (2022-2029) 5.4.7. Austria 5.4.7.1. Austria Heparin Market Size and Forecast, by Product Type (2022-2029) 5.4.7.2. Austria Heparin Market Size and Forecast, by End-User (2022-2029) 5.4.7.3. Austria Heparin Market Size and Forecast, by Route of Administration (2022-2029) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Heparin Market Size and Forecast, by Product Type (2022-2029) 5.4.8.2. Rest of Europe Heparin Market Size and Forecast, by End-User (2022-2029) 5.4.8.3. Rest of Europe Heparin Market Size and Forecast, by Route of Administration (2022-2029) 6. Asia Pacific Heparin Market Size and Forecast by Segmentation (by Value and Volume) 2022-2029 6.1. Asia Pacific Heparin Market Size and Forecast, by Product Type (2022-2029) 6.2. Asia Pacific Heparin Market Size and Forecast, by End-User (2022-2029) 6.3. Asia Pacific Heparin Market Size and Forecast, by Route of Administration (2022-2029) 6.4. Asia Pacific Heparin Market Size and Forecast, by Country (2022-2029) 6.4.1. China 6.4.1.1. China Heparin Market Size and Forecast, by Product Type (2022-2029) 6.4.1.2. China Heparin Market Size and Forecast, by End-User (2022-2029) 6.4.1.3. China Heparin Market Size and Forecast, by Route of Administration (2022-2029) 6.4.2. S Korea 6.4.2.1. S Korea Heparin Market Size and Forecast, by Product Type (2022-2029) 6.4.2.2. S Korea Heparin Market Size and Forecast, by End-User (2022-2029) 6.4.2.3. S Korea Heparin Market Size and Forecast, by Route of Administration (2022-2029) 6.4.3. Japan 6.4.3.1. Japan Heparin Market Size and Forecast, by Product Type (2022-2029) 6.4.3.2. Japan Heparin Market Size and Forecast, by End-User (2022-2029) 6.4.3.3. Japan Heparin Market Size and Forecast, by Route of Administration (2022-2029) 6.4.4. India 6.4.4.1. India Heparin Market Size and Forecast, by Product Type (2022-2029) 6.4.4.2. India Heparin Market Size and Forecast, by End-User (2022-2029) 6.4.4.3. India Heparin Market Size and Forecast, by Route of Administration (2022-2029) 6.4.5. Australia 6.4.5.1. Australia Heparin Market Size and Forecast, by Product Type (2022-2029) 6.4.5.2. Australia Heparin Market Size and Forecast, by End-User (2022-2029) 6.4.5.3. Australia Heparin Market Size and Forecast, by Route of Administration (2022-2029) 6.4.6. Indonesia 6.4.6.1. Indonesia Heparin Market Size and Forecast, by Product Type (2022-2029) 6.4.6.2. Indonesia Heparin Market Size and Forecast, by End-User (2022-2029) 6.4.6.3. Indonesia Heparin Market Size and Forecast, by Route of Administration (2022-2029) 6.4.7. Malaysia 6.4.7.1. Malaysia Heparin Market Size and Forecast, by Product Type (2022-2029) 6.4.7.2. Malaysia Heparin Market Size and Forecast, by End-User (2022-2029) 6.4.7.3. Malaysia Heparin Market Size and Forecast, by Route of Administration (2022-2029) 6.4.8. Vietnam 6.4.8.1. Vietnam Heparin Market Size and Forecast, by Product Type (2022-2029) 6.4.8.2. Vietnam Heparin Market Size and Forecast, by End-User (2022-2029) 6.4.8.3. Vietnam Heparin Market Size and Forecast, by Route of Administration(2022-2029) 6.4.9. Taiwan 6.4.9.1. Taiwan Heparin Market Size and Forecast, by Product Type (2022-2029) 6.4.9.2. Taiwan Heparin Market Size and Forecast, by End-User (2022-2029) 6.4.9.3. Taiwan Heparin Market Size and Forecast, by Route of Administration (2022-2029) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Heparin Market Size and Forecast, by Product Type (2022-2029) 6.4.10.2. Rest of Asia Pacific Heparin Market Size and Forecast, by End-User (2022-2029) 6.4.10.3. Rest of Asia Pacific Heparin Market Size and Forecast, by Route of Administration (2022-2029) 7. Middle East and Africa Heparin Market Size and Forecast by Segmentation (by Value and Volume) 2022-2029 7.1. Middle East and Africa Heparin Market Size and Forecast, by Product Type (2022-2029) 7.2. Middle East and Africa Heparin Market Size and Forecast, by End-User (2022-2029) 7.3. Middle East and Africa Heparin Market Size and Forecast, by Route of Administration (2022-2029) 7.4. Middle East and Africa Heparin Market Size and Forecast, by Country (2022-2029) 7.4.1. South Africa 7.4.1.1. South Africa Heparin Market Size and Forecast, by Product Type (2022-2029) 7.4.1.2. South Africa Heparin Market Size and Forecast, by End-User (2022-2029) 7.4.1.3. South Africa Heparin Market Size and Forecast, by Route of Administration (2022-2029) 7.4.2. GCC 7.4.2.1. GCC Heparin Market Size and Forecast, by Product Type (2022-2029) 7.4.2.2. GCC Heparin Market Size and Forecast, by End-User (2022-2029) 7.4.2.3. GCC Heparin Market Size and Forecast, by Route of Administration (2022-2029) 7.4.3. Nigeria 7.4.3.1. Nigeria Heparin Market Size and Forecast, by Product Type (2022-2029) 7.4.3.2. Nigeria Heparin Market Size and Forecast, by End-User (2022-2029) 7.4.3.3. Nigeria Heparin Market Size and Forecast, by Route of Administration (2022-2029) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Heparin Market Size and Forecast, by Product Type (2022-2029) 7.4.4.2. Rest of ME&A Heparin Market Size and Forecast, by End-User (2022-2029) 7.4.4.3. Rest of ME&A Heparin Market Size and Forecast, by Route of Administration (2022-2029) 8. South America Heparin Market Size and Forecast by Segmentation (by Value and Volume) 2022-2029 8.1. South America Heparin Market Size and Forecast, by Product Type (2022-2029) 8.2. South America Heparin Market Size and Forecast, by End-User (2022-2029) 8.3. South America Heparin Market Size and Forecast, by Route of Administration(2022-2029) 8.4. South America Heparin Market Size and Forecast, by Country (2022-2029) 8.4.1. Brazil 8.4.1.1. Brazil Heparin Market Size and Forecast, by Product Type (2022-2029) 8.4.1.2. Brazil Heparin Market Size and Forecast, by End-User (2022-2029) 8.4.1.3. Brazil Heparin Market Size and Forecast, by Route of Administration (2022-2029) 8.4.2. Argentina 8.4.2.1. Argentina Heparin Market Size and Forecast, by Product Type (2022-2029) 8.4.2.2. Argentina Heparin Market Size and Forecast, by End-User (2022-2029) 8.4.2.3. Argentina Heparin Market Size and Forecast, by Route of Administration (2022-2029) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Heparin Market Size and Forecast, by Product Type (2022-2029) 8.4.3.2. Rest Of South America Heparin Market Size and Forecast, by End-User (2022-2029) 8.4.3.3. Rest Of South America Heparin Market Size and Forecast, by Route of Administration (2022-2029) 9. Global Heparin Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Production of 2022 9.3.6. Company Locations 9.4. Leading Heparin Market Companies, by market capitalization 9.5. Analysis of Organized and Unorganized Key Players in Heparin Industry 9.6. Market Structure 9.6.1. Market Leaders 9.6.2. Market Followers 9.6.3. Emerging Players 9.7. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Baxter International Inc. (US) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. B. Braun Holding GmbH & Co. KG (Germany) 10.3. Dr. Reddy’s Laboratories Ltd (India) 10.4. Fresenius SE & Co KGaA (Germany) 10.5. Hebei Changshan Biochemical Pharmaceutical Co. Ltd (China) 10.6. Leo Pharma A/S (Denmark) 10.7. Pfizer Inc. (NY, US) 10.8. Sanofi S.A. (Paris, France) 10.9. Teva Pharmaceuticals (Israel) 10.10. Viatris Inc. (US) 10.11. Amphastar (US) 10.12. Sanofi (France) 10.13. Rovi (Spain) 10.14. Shenzhen Hepalink (China) 11. Key Findings 12. Industry Recommendations 13. Heparin Market: Research Methodology 14. Terms and Glossary

About This Report

Report ID 103436
Category Healthcare
Published Date July 2023
Updated Date
  • INQUIRE BEFORE BUYING